October 18, 2004

IN RE: Merck & Co., Inc., Securities, Derivative & "ERISA" Litigation

Track this case

Case Number:

1658

Court:

Judicial Panel on Multidistrict Litigation

Nature of Suit:

Judge:

Stanley R. Chesler

Firms

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. May 13, 2015

    Merck Nabs Partial Win In Vioxx Securities Fraud Row

    A New Jersey federal judge ruled Wednesday that a class alleging securities fraud could not prove Merck & Co. Inc. misrepresented Vioxx's heart attack risks at least prior to a study comparing the arthritis medication with another leading drug, but could still prove Merck misled investors after learning of the study results.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login